Skip to main content
. 2015 Nov-Dec;77(6):764–770. doi: 10.4103/0250-474x.174970

Fig. 6.

Fig. 6

Release rate profile of dexamethasone sodium phosphate from in situ gelling system containing Klucel HF.

Release rate profile of dexamethasone sodium phosphate from in situ otic formulations P3K1 (Inline graphic), P3K2 (Inline graphic) and P3K3 (Inline graphic) containing poloxamer (19% w/v) with Klucel HF (0.5, 1.0 and 1.5% w/v), respectively. Results are mean of three observations, ±standard deviation.